In addition to these treatments, considering that GLI1 is crucial for the development of cancer downstream of HH signalling, PRMT5 inhibitors53 and discovery of drugs targeting the binding of MEP50/PRMT5 and GLI1 may be useful for cancer treatment. The gene discussed is PRMT5; the disease is cancer.